This HTML5 document contains 112 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37105397
rdf:type
wikibase:Item
schema:description
scientific article published on 31 March 2006 наукова стаття, опублікована в березні 2006 artigo científico научни чланак vedecký článok wetenschappelijk artikel مقالة علمية نشرت في 31 مارس 2006 articolo scientifico wissenschaftlicher Artikel artículu científicu espublizáu en 2006 bilimsel makale article scientifique vetenskaplig artikel videnskabelig artikel article científic vědecký článek
p:P577
wds:Q37105397-66752C4D-8098-47A0-ACB6-65C06DCA887D
wdt:P577
2006-03-31T00:00:00Z
p:P407
wds:Q37105397-E4DE3C47-2D5F-42CF-A547-BCCC99B4866C
wdt:P407
wd:Q1860
p:P2860
wds:Q37105397-59EFBCBA-BA35-4E15-9E76-372A7360A177 wds:Q37105397-60635E42-DD00-4A05-B3E9-B1A7250D0275 wds:Q37105397-624BF909-7021-450A-B649-F9C1DCCC9C9B wds:Q37105397-910A5EDF-6968-4927-AE34-E73528D03265 wds:Q37105397-92440A65-45CF-4953-B2DE-931DDE90F013 wds:Q37105397-B17E639F-23B1-48AF-A859-E348DB8BFB97 wds:Q37105397-B77F42D0-4BA7-477D-AA86-937A01557260 wds:Q37105397-B99636A3-F7A5-4FCC-812A-84578329E323 wds:Q37105397-C49E2F97-C376-4FAF-9F49-96001181BBB0 wds:Q37105397-CB9DB597-B020-44EC-A2DB-1F355D92CFCA wds:Q37105397-0470F57B-8BFD-45A6-8F07-FEF4E2962947 wds:Q37105397-0D5413DC-8B3B-45A3-B4FD-C5A02F73AF2B wds:Q37105397-1F7B3112-4CFC-4914-B1D6-158DA640702C wds:Q37105397-2E013448-E5B2-4A0D-8828-476047A40E19 wds:Q37105397-30CCC4AF-FF0C-48FA-8E23-BBCA23DDC144 wds:Q37105397-338D40DB-D000-4322-95B9-849C31E29E1F wds:Q37105397-3A18DB3F-EF8D-4E9B-A36E-5124D8F83F70 wds:Q37105397-45BB795F-E180-4B38-B363-CDB462F79817
wdt:P2860
wd:Q40881727 wd:Q69585210 wd:Q78483448 wd:Q44881299 wd:Q77212696 wd:Q57908152 wd:Q81079607 wd:Q52005044 wd:Q72998323 wd:Q43899350 wd:Q24299714 wd:Q35372794 wd:Q40891663 wd:Q39555048 wd:Q46141403 wd:Q34117188 wd:Q37355630 wd:Q77835138
p:P2093
wds:Q37105397-0F8F6EFD-28B7-45AB-9811-CB9C77A03324
wdt:P2093
Stefania Bandinelli
rdfs:label
Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study).
skos:prefLabel
Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age
schema:name
Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study). Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age
p:P50
wds:Q37105397-535FA342-09E6-4BA5-A829-634C6192F192 wds:Q37105397-5682C29B-4E43-4013-A5BF-8860CDFBA68F wds:Q37105397-2A514437-DEA1-4A8E-A43B-030E9485DCA4 wds:Q37105397-0AC35A39-095E-4AD4-A14D-C06B9D2EE713 wds:Q37105397-F47C4F55-A936-4DDE-8773-0940FB2C48BB wds:Q37105397-C6A6AF03-7970-4DAA-90CB-E518D3664EB4 wds:Q37105397-9BFF5831-CE0C-4BB0-AA8F-9FFC335B6120 wds:Q37105397-6DD886DE-1A55-4904-80DB-E8F7F412BE88 wds:Q37105397-8519C93E-0309-40B9-8090-EE496DDD7EAE wds:Q37105397-593B1FDD-FAF5-473C-AAEE-D5B534E85CA4
wdt:P50
wd:Q114240228 wd:Q79885968 wd:Q114434697 wd:Q92591826 wd:Q28050062 wd:Q43120816 wd:Q39885610 wd:Q44358165 wd:Q114434699 wd:Q114322622
p:P1476
wds:Q37105397-FD107864-1EC0-4AA3-ACF3-FA834053387D
wdt:P1476
Relation of angiotensin-converting enzyme inhibitor treatment to insulin-like growth factor-1 serum levels in subjects >65 years of age (the InCHIANTI study)
p:P304
wds:Q37105397-4535CFB5-80A6-4CD1-A051-FCCB86F8904F
wdt:P304
1525-1529
p:P31
wds:Q37105397-E053378B-C424-4673-B867-55232601FA0D
wdt:P31
wd:Q13442814
p:P921
wds:Q37105397-9E143B6C-6853-4615-B38F-07E4C4FF87EC
wdt:P921
wd:Q7240673
p:P698
wds:Q37105397-51D81B42-F434-421D-9886-BDA3E2488A6D
wdtn:P698
n11:16679098
wdt:P698
16679098
p:P1433
wds:Q37105397-0B0C1591-970B-44C3-98AB-D6582761CC75
wdt:P1433
wd:Q2208417
p:P433
wds:Q37105397-BCFF7D6B-0606-4470-96BD-F0046C78396E
p:P478
wds:Q37105397-E5965561-16F9-4D25-8FBF-9087565C611B
wdt:P433
10
wdt:P478
97
p:P356
wds:Q37105397-0550835C-237D-4E1B-B84C-C2B1B8E5A679
wdtn:P356
n10:J.AMJCARD.2005.11.089
wdt:P356
10.1016/J.AMJCARD.2005.11.089
p:P5875
wds:Q37105397-D8750810-D42B-47C0-AD81-23B8F31400B4
wdt:P5875
7102216
p:P932
wds:Q37105397-192A7212-356D-4D20-9CB9-82140778C177
wdt:P932
2646084